Glenmark to conduct trials in India for potential COVID-19 drug
[ad_1] BENGALURU (Reuters) – Glenmark Prescription drugs Ltd GLEN.NS stated on Thursday it can begin medical trials in India of antiviral drug favipiravir, seen as a possible therapy for COVID-19, sending its shares up as a lot as 9%. The trials come after a Chinese language official advised reporters final month that an energetic ingredient… Read More »